{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:42:41Z","timestamp":1793378561289,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.euo.2025.04.008","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T03:54:04Z","timestamp":1752724444000},"page":"961-967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Years of Life Lost in Metastatic and Locally Advanced Prostate Cancer"],"prefix":"10.1016","volume":"8","author":[{"given":"Fabian","family":"Falkenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh Chi","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Longoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marmiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Nicolazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Polverino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Musi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix K.H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild","family":"von Amsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Steuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.04.008_b0005","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. Cancer stat facts: prostate cancer; 2025. https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html."},{"key":"10.1016\/j.euo.2025.04.008_b0010","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/ije\/dyy254","article-title":"Reflection on modern methods: years of life lost due to premature mortality-a versatile and comprehensive measure for monitoring non-communicable disease mortality","volume":"48","author":"Martinez","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.euo.2025.04.008_b0015","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/pros.24360","article-title":"Current and projected number of years of life lost due to prostate cancer: a global study","volume":"82","author":"Withrow","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2025.04.008_b0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/pros.24178","article-title":"Sociodemographic index and global trends in prostate cancer: 1990\u20132017","volume":"81","author":"Launer","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2025.04.008_b0025","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s11255-023-03653-7","article-title":"Regional and national burden of prostate cancer: incidence, mortality, years of life lost, and disability-adjusted life years, in Mexico and Latin America from 1990 to 2019","volume":"55","author":"Guzman-Esquivel","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euo.2025.04.008_b0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.008_b0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.008_b0040","unstructured":"National Comprehensive Cancer Network, Inc. NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) for prostate cancer V.1.2025. 2025."},{"key":"10.1016\/j.euo.2025.04.008_b0045","unstructured":"Social Security Administration. Period life table 2004\u20132021; 2024. https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html."},{"key":"10.1016\/j.euo.2025.04.008_b0050","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.euf.2018.05.006","article-title":"Validation of the social security administration life tables (2004\u20132014) in localized prostate cancer patients within the Surveillance, Epidemiology, and End Results database","volume":"5","author":"Preisser","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.04.008_b0055","unstructured":"NCI. Definition of premature death. NCI dictionary of cancer terms; 2011. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/premature-death."},{"key":"10.1016\/j.euo.2025.04.008_b0060","unstructured":"Posit team, Posit Software, PBC. RStudio: integrated development environment for R; 2023. http:\/\/www.posit.co\/."},{"key":"10.1016\/j.euo.2025.04.008_b0065","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/cncr.24324","article-title":"Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study","volume":"115","author":"Lin","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.04.008_b0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cncr.22736","article-title":"Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE","volume":"110","author":"Ryan","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.04.008_b0075","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1007\/s00345-021-03785-4","article-title":"Clinical outcomes and prognosis of metastatic prostate cancer patients\u2009\u2264\u200960-year-old","volume":"39","author":"Kim","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.04.008_b0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00345-019-02740-8","article-title":"Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men\u2009\u2264\u200945 years of age","volume":"38","author":"Tilki","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.04.008_b0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00345-023-04287-1","article-title":"Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?","volume":"41","author":"Mehring","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.04.008_b0090","unstructured":"National Cancer Institute, NIH. Cancer trends progress report; 2024. https:\/\/progressreport.cancer.gov\/end\/life_lost."},{"key":"10.1016\/j.euo.2025.04.008_b0095","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.04.008_b0100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41419-022-05084-1","article-title":"Second generation androgen receptor antagonists and challenges in prostate cancer treatment","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.euo.2025.04.008_b0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.euros.2024.06.010","article-title":"Contemporary treatment patterns and oncological outcomes of metastatic hormone-sensitive prostate cancer and first- to sixth- line metastatic castration-resistant prostate cancer patients","volume":"66","author":"Wenzel","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2025.04.008_b0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eururo.2016.05.011","article-title":"Trends in the incidence of fatal prostate cancer in the United States by race","volume":"71","author":"Kelly","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.008_b0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41391-021-00451-z","article-title":"Racial disparities in prostate cancer among black men: epidemiology and outcomes","volume":"25","author":"Chowdhury-Paulino","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2025.04.008_b0120","first-page":"290","article-title":"Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities","volume":"66","author":"DeSantis","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.04.008_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/560857","article-title":"Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of African descent","volume":"2013","author":"Rebbeck","year":"2013","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.euo.2025.04.008_b0130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","article-title":"Association of Black race with prostate cancer-specific and other-cause mortality","volume":"5","author":"Dess","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2025.04.008_b0135","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.22.02203","article-title":"Racism does not cause prostate cancer, it causes prostate cancer death","volume":"41","author":"Vickers","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.04.008_b0140","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.urolonc.2019.04.023","article-title":"Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: a population-based study","volume":"37","author":"Knipper","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.04.008_b0145","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/1055-9965.EPI-23-1207","article-title":"Marital status, living arrangement, and survival among individuals with advanced prostate cancer in the International Registry for Men with Advanced Prostate Cancer","volume":"33","author":"Chen","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euo.2025.04.008_b0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.04.008_b0155","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1200\/JCO.19.00799","article-title":"ARCHES: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer","volume":"37","author":"Armstrong","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:20:34Z","timestamp":1758079234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125001026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2588931125001026"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.04.008","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Years of Life Lost in Metastatic and Locally Advanced Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}